Omic and Multidimensional Spatial Atlas of Metastatic Breast Cancer
转移性乳腺癌的组学和多维空间图谱
基本信息
- 批准号:10818062
- 负责人:
- 金额:$ 92.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-04 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAccelerationAftercareAtlasesBiologicalBiological AssayBiological MarkersBiological ProcessBiopsyBloodBreast Cancer TreatmentCDK4 geneCellsChromatinClinicalCollectionCommunitiesCore BiopsyCoupledDNA sequencingDataData AnalysesData Coordinating CenterData SetDevelopmentDiagnostic ProcedureDimensionsElectron MicroscopeEvaluationFormalinFoundationsFreezingGenerationsGenomicsGoalsHeterogeneityImageImmune checkpoint inhibitorImmunofluorescence ImmunologicImmunohistochemistryIonsMalignant NeoplasmsManuscriptsMapsMetadataMetastatic breast cancerMolecularNoninfiltrating Intraductal CarcinomaParaffin EmbeddingPathway interactionsPatientsPeriodicityPlant ResinsPoly(ADP-ribose) Polymerase InhibitorPublicationsResistanceResource SharingResourcesSamplingScanningScientistSpecimenStructureTherapeuticThree-Dimensional ImageTimeTissuesTumor-DerivedVisualizationWorkanticancer researchbiological systemscancer subtypescohortdata integrationdata sharinghormone receptor-positivehormone therapyimmune checkpointimmune modulating agentsindividual patientinhibitorinnovationmalignant breast neoplasmmultimodal datamultimodalityneoplastic cellnovelnovel diagnosticsnovel therapeutic interventionnovel therapeuticsoperationparaformprogramsprospectiveresistance mechanismsample collectionsuccesstargeted treatmenttherapy resistanttooltreatment responsetriple-negative invasive breast carcinomatumortumor-immune system interactions
项目摘要
PROJECT ABSTRACT
We will continue development of our Omic and Multidimensional Spatial (OMS) Atlas that enables discovery of
mechanisms of resistance that arise in individual patients with metastatic breast cancer during treatment with
current generation targeted therapeutic combinations and immune checkpoint inhibitors. The OMS Atlas is
motivated by the fact that these treatments typically are only transiently effective in the metastatic setting.
Possible resistance mechanisms may be intrinsic to the tumor cells or derive from the diverse microenvironments
in which the tumor cells live. The OMS Atlas focuses on elucidating these resistance mechanisms in two current
generation clinical scenarios: (a) hormone-receptor positive breast cancer (HRBC) undergoing treatment with a
CDK4/6 inhibitor in combination with endocrine therapy, and (b) triple negative breast cancer (TNBC) undergoing
treatment with a PARP inhibitor and an immunomodulatory agent. We are accomplishing this through work via
four coordinated units. A Biospecimen Unit is prospectively collecting and distributing longitudinal clinical
information, blood, and biopsies from 30 cases across the two metastatic breast cancer cohorts. A
Characterization Unit is analyzing (a) OCT frozen specimens using single-cell DNA-seq and single-cell ATAC-
seq to elucidate spatially defined genomic changes and chromatin accessibility in single cells, (b) formalin fixed,
paraffin embedded (FFPE) specimens using multiplex immunohistochemistry (mIHC) to assess the immune
microenvironment and cyclic Immunofluorescence (cycIF) to assess the composition and molecular states of
tumor cells and their microenvironments, and (c) paraformaldehyde fixed, resin embedded (PFRE) specimens
using a Focused Ion Beam Scanning Electron Microscope (FIB-SEM) to identify ultrastructural changes in 2D
images and targeted 3D images. Omic characterization of the same tumor samples is provided by the SMMART
Program. A Data Analysis Unit is developing and deploying tools to (a) manage, analyze, and visualize omics
and imaging datasets, (b) integrate omics and imaging datasets through crosswise mapping to create single
timepoint tumor maps and quantify systems biological functions of tumor cellular subpopulations, and (c) explore
differences between pre- and on/post-treatment tumor maps to reveal mechanisms of resistance. The
Administrative Unit facilitates the coordination, operation, interaction, and evaluation of activities within the OMS
Atlas and between OMS Atlas scientists and the HTAN. In this project, we will complete our planned OMS Atlas
project through the following Aims: (1) perform characterization of five additional patient cases using our omics
and multiscale imaging assays; (2) upload our remaining datasets and metadata to the HTAN data coordinating
center; and (3) perform integrated data analysis across our atlas case datasets as well as HTAN trans-network
project datasets to identify tumor changes on therapy and the implications of those changes on breast cancer
treatment. By accomplishing these aims we will complete and fully share our multimodal spatial atlas of 30
metastatic breast cancer cases undergoing treatment.
项目摘要
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Quality Control for Single Cell Analysis of High-plex Tissue Profiles using CyLinter.
使用 CyLinter 对高复合组织概况进行单细胞分析的质量控制。
- DOI:10.1101/2023.11.01.565120
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Baker,GregoryJ;Novikov,Edward;Zhao,Ziyuan;Vallius,Tuulia;Davis,JanaeA;Lin,Jia-Ren;Muhlich,JeremyL;Mittendorf,ElizabethA;Santagata,Sandro;Guerriero,JenniferL;Sorger,PeterK
- 通讯作者:Sorger,PeterK
Author Correction: Towards community-driven metadata standards for light microscopy: tiered specifications extending the OME model.
作者更正:迈向社区驱动的光学显微镜元数据标准:扩展 OME 模型的分层规范。
- DOI:10.1038/s41592-021-01386-y
- 发表时间:2022
- 期刊:
- 影响因子:48
- 作者:Hammer,Mathias;Huisman,Maximiliaan;Rigano,Alessandro;Boehm,Ulrike;Chambers,JamesJ;Gaudreault,Nathalie;North,AlisonJ;Pimentel,JaimeA;Sudar,Damir;Bajcsy,Peter;Brown,ClaireM;Corbett,AlexanderD;Faklaris,Orestis;Lacoste,Judith;
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emek Demir其他文献
Emek Demir的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emek Demir', 18)}}的其他基金
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
- 批准号:
10471932 - 财政年份:2018
- 资助金额:
$ 92.33万 - 项目类别:
Measuring, Modeling and Controlling Heterogeneity
测量、建模和控制异质性
- 批准号:
10166783 - 财政年份:2017
- 资助金额:
$ 92.33万 - 项目类别:
OHSU Center for Specialized Data Analysis as part of the GDAN
OHSU 专业数据分析中心作为 GDAN 的一部分
- 批准号:
10004583 - 财政年份:2016
- 资助金额:
$ 92.33万 - 项目类别:
相似海外基金
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 92.33万 - 项目类别:
Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
- 批准号:
2307983 - 财政年份:2023
- 资助金额:
$ 92.33万 - 项目类别:
Standard Grant